Effect of Kangai No.2 prescription on immune system of patients with advanced colorectal cancer: a randomized controlled study

Phase 1

Not yet recruiting

• Conditions: Colorectal cancer

• Registration Number: ITMCTR2000003633
• Lead Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) Patients with stage IV colorectal cancer with definite pathological diagnosis;
(2) Patients aged between 18 and 80 years old;
(3) There were no serious virus and bacterial infection, no organ failure and serious heart disease;
(4) There were no other serious complications;
(5) I agreed to participate in the study and signed the informed consent form after being informed, and the compliance was good.
(6) There was no allergic reaction to the compatible ingredients in the prescription.

Exclusion Criteria

(1) Patients who are receiving other drug intervention treatment (including other Chinese herbal pieces, chemotherapy, targeted drugs);
(2) Patients with mental illness themselves, those with lack of autonomous behavior ability, and those with mental disorders have no independent behavior ability;
(3) Pregnant, ready for pregnancy or lactation.
(4) Combined with heart, lung, brain, liver, kidney and hematopoietic system and other serious diseases, mental patients.
(5) Allergic constitution or known allergy to the components of the drug.
(6) Patients who are participating in other clinical trials or have participated in other clinical trials within 3 months.
(7) Alcoholism and / or psychoactive substances, drug abusers and addicts.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
survival rate;Tumor recurrence rate;